Company: Duopharma Biotech Berhad

Bloomberg ticker: DBB MK

Market cap: US$454m

Background: Duopharma Biotech Berhad engages in the R&D and commercialization of chemical and pharmaceutical products. Its products include antibiotics, hemodialysis solution, sterile irrigation solution, sterile powder injectables, dental cartridges, and eye drop preparations. DBB is headquartered in Klang, Malaysia.

World Class Benchmarking of Duopharma Biotech

---

---

 

• Profitable Growth rank of 5 was same compared to the prior period’s 5th rank
• This is average performance compared to 410 medium Health Care companies worldwide
• Profitability rank of 5 was the same as its Growth rank of 5
• Profitability rank of 5 was the same compared to the prior period’s 5th rank
• This is average performance compared to peers
• Growth rank of 5 was the same compared to the prior period’s 5th rank
• This is average performance compared to peers

 

---

DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.